What is Castle Biosciences's current ratio?

Castle Biosciences (CSTL) reported current ratio of 6.7× in Q1 2026.

How has Castle Biosciences's current ratio changed year-over-year?

Castle Biosciences's current ratio decreased by 28.0% year-over-year, from 9.4× to 6.7×.

What is the long-term trend for Castle Biosciences's current ratio?

Over 5 years (2020 to 2025), Castle Biosciences's current ratio has grown at a -23.9% compound annual growth rate (CAGR), from 20.6× to 5.3×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Castle Biosciences CSTL Current ratio

Current ratio at other companies

Labcorp HoldingsLH

1.7×-0.1×

VeracyteVCYT

9.3×+4.2×

Personalis, Inc.PSNL

6.6×-0.3×

NeoGenomicsNEO

4.4×+2.4×

Fulgent Genetics, Inc.FLGT

5.3×-1.0×

Cogent Biosciences, Inc.COGT

15.1×+10.0×

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Where this comes from

Calculated from Castle Biosciences’s reported figures.

total current assets/total current liabilities=6.7×

Based on the most recent quarter.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's current ratio?: Castle Biosciences (CSTL) reported current ratio of 6.7× in Q1 2026.
How has Castle Biosciences's current ratio changed year-over-year?: Castle Biosciences's current ratio decreased by 28.0% year-over-year, from 9.4× to 6.7×.
What is the long-term trend for Castle Biosciences's current ratio?: Over 5 years (2020 to 2025), Castle Biosciences's current ratio has grown at a -23.9% compound annual growth rate (CAGR), from 20.6× to 5.3×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.